- US-listed companies
- Hoth Therapeutics, Inc.
- Income statement
Hoth Therapeutics, Inc.HOTH
Market cap
$13.92M
P/E ratio
| 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Research & development | 785,274 | 2 | 2 | 7 | 5 | 3 | 3 |
| Operating income | -2,495,525 | -7,714,997 | -7,301,974 | -14,101,440 | -11,065,554 | -7,692,242 | -8,215,432 |
| Operating expenses | 2 | 8 | 7 | 14 | 11 | 8 | 8 |
| Net income | -2,495,525 | -7,704,636 | -7,197,816 | -14,313,705 | -11,371,953 | -7,845,390 | -8,188,300 |
| Earnings per share | - | - | - | - | -9.5 | -2.3 | -1.28 |
| Diluted EPS | - | - | - | - | -9.5 | -2.3 | -1.28 |